From Wikipedia, the free encyclopedia
Jump to: navigation, search
edit·history·watch·refresh Stock post message.svg To-do list for Myopathy:

Strike through when completed

  • Expand infobox
  • Expand individual examples of myopathy
  • Create articles on WP for individual disorders of the myopathy class (some names are currently wikilinked to... proteins)
  • Update the classification based on eMedicine or OMIM since ICD-10, of 1992, is hardly based on modern genetics-based understanding (for example, it does not include distal myopathies 160500, 606070, etc.)
  • Still, link ICD-10 codes where relevant
WikiProject Medicine / Medical genetics / Neurology (Rated Start-class, Mid-importance)
WikiProject icon This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.
Start-Class article Start  This article has been rated as Start-Class on the project's quality scale.
 Mid  This article has been rated as Mid-importance on the project's importance scale.
Taskforce icon
This article is supported by the Medical genetics task force.
Taskforce icon
This article is supported by the Neurology task force (marked as Mid-importance).

"Can be caused by STATINS!"[edit]

This does not appear to be the most encyclopedia-formatted set of edits in the world, yielding:

...but the info, if legit, looks like it should be in the article. Can a subject matter expert review/edit/reformat? Thanks, --NapoliRoma (talk) 21:32, 12 April 2011 (UTC)

FDA warns for Simvastatin June 2011[edit]

After what doctors characterize as a 10 year delay in recognizing Simvastatin myopathological effects, the FDA today is headlined in national press warning for these possible effects of Simvastatin use. (It apparently is widely used, and in Sweden is the first choice statin in general practice). See further

This, I feel is a major matter:

1) Compared to the frequency, I presume, of congenital and acquired myopathy, this is a widely used drug by large population groups, and thus may be a major health concern. Thus it is in the public interest that this need for information be met.

2) While no connection is described in the FDA notice, one can from a layman's POV regard with suspicion Simvastatin's possible effect vis-a-vis cardiomyopathy. Which is of course a problem with mortality links, compared to skelett-musculopathy.

(On an episodic level, I stopped using it for 8 years ago after six months incapacitating use, due to pain when standing, etc. Have used Atorvastatin since with no side effects and better effect on cholesterol levels.) -- Idealist707 (talk) 21:25, 10 June 2011 (UTC)

No mention of Myofibrillar myopathy[edit]

which (by default) redirects here. - Rod57 (talk) 00:17, 10 November 2016 (UTC)